Public Consultation Response | 5 November 2024 | Download Response

The European Medicines Agency (EMA) held a public consultation on their Policy 0044 – handling competing interests of scientific committee members and experts.

It is crucial that the EMA ensures impartiality and eradicates biased interests in the conduct of its activities. As competing interest policies vary across regulators, the EMA must aspire to setting the highest standard.

With regard to the growing overlap between regulatory affairs, research as well as lobbying and outreach activities, we call for a more granular approach to uphold the highest ethical standards for professionals once engaged in providing expertise or assisting in the conduct of EMA activities.

Download our full response here.